ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,169,000 | +39.2% | 18,412 | +1.5% | 0.00% | +100.0% |
| Q2 2021 | $2,276,000 | -5.4% | 18,138 | +2.2% | 0.00% | -50.0% |
| Q1 2021 | $2,406,000 | +16.7% | 17,740 | +10.1% | 0.00% | 0.0% |
| Q4 2020 | $2,061,000 | +21.5% | 16,107 | +6.9% | 0.00% | 0.0% |
| Q3 2020 | $1,696,000 | +300.9% | 15,071 | +239.3% | 0.00% | – |
| Q2 2020 | $423,000 | -4.9% | 4,442 | -10.4% | 0.00% | -100.0% |
| Q1 2020 | $445,000 | +19.3% | 4,955 | -29.6% | 0.00% | – |
| Q4 2019 | $373,000 | +62.2% | 7,041 | +21.1% | 0.00% | – |
| Q3 2019 | $230,000 | -2.5% | 5,814 | +1.2% | 0.00% | – |
| Q2 2019 | $236,000 | -4.8% | 5,745 | +7.9% | 0.00% | – |
| Q1 2019 | $248,000 | 0.0% | 5,323 | -6.5% | 0.00% | – |
| Q4 2018 | $248,000 | +892.0% | 5,695 | +1025.5% | 0.00% | – |
| Q2 2018 | $25,000 | +8.7% | 506 | -14.5% | 0.00% | – |
| Q1 2018 | $23,000 | -4.2% | 592 | +5.9% | 0.00% | – |
| Q4 2017 | $24,000 | -4.0% | 559 | -14.4% | 0.00% | – |
| Q3 2017 | $25,000 | -75.2% | 653 | -80.3% | 0.00% | – |
| Q2 2017 | $101,000 | +21.7% | 3,307 | +5.2% | 0.00% | – |
| Q1 2017 | $83,000 | -15.3% | 3,143 | -18.0% | 0.00% | – |
| Q4 2016 | $98,000 | -33.8% | 3,831 | -6.3% | 0.00% | -100.0% |
| Q3 2016 | $148,000 | +2.8% | 4,089 | -3.7% | 0.00% | 0.0% |
| Q2 2016 | $144,000 | +77.8% | 4,248 | +38.3% | 0.00% | – |
| Q1 2016 | $81,000 | -51.8% | 3,071 | -10.7% | 0.00% | -100.0% |
| Q4 2015 | $168,000 | +140.0% | 3,438 | +22.7% | 0.00% | – |
| Q3 2015 | $70,000 | – | 2,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |